【摘 要】
：
We are developing a monoclonal antibody that recognizes an oncofetal glycoepitope as a potential probe for identifying cancer stem cells.Mannitou antibody labels significantly more restrictively in se
【机 构】
：
Department of Physiology Michigan State University USA
论文部分内容阅读
We are developing a monoclonal antibody that recognizes an oncofetal glycoepitope as a potential probe for identifying cancer stem cells.Mannitou antibody labels significantly more restrictively in sections of human colon carcinoma than anti-Human cytokeratin 20.Furthermore, Mannitou antibody intensely labels the surface of human adult pancreatic stem cells and pancreatic cancer cell lines.Within inflamed mouse pancreata, it labels the exocrine ducts, the site of adult stem cells.
其他文献
Background.Donor specific antibodies (DSA) are associated with acute kidney graft rejection, but their role in small bowel (SBT)/multivsceral (MVT) allograft remains unclear.We carried out a prospecti
The monoclonal antibody D32.10, raised against serum-derived Hepatitis C virus (HCVsp), recognizes a highly conserved discontinuous antigenic determinant: E1 (aa297-306), E2(aa480-494 and E2(aa613-621
The monoclonal antibody D32.10, raised against serum-derived Hepatitis C virus (HCVsp), recognizes a highly conserved discontinuous antigenic determinant: El (aa297-306), E2(aa480-494 and E2(aa613-621
Botulinum neurotoxins (BoNTs) and ricin are some of the most potent humans toxins described.The most common route of intoxication is through ingestion of contaminated food or drink.In addition, these
Cancer immunotherapy, particularly antigen-specific cancer vaccines, has emerged as an attractive approach due to their ability to kill tumor cells without harming normal cells.The understanding ofonc
TLP is a tumor-associated antigen and a 100 kDa protein overexpressed in lung tumors and other epithelial adenocarcinomas.It is immunogenic in humans as shown by serum antibodies.Since TLP is a fragme
Members of the Camelidae family produce immunoglobulins devoid of light chains.We have characterized variable domain fragments of these heavy chain antibodies, the VHH, from llamas immunized with huma
The emerging use of non-immunoglobulin derived protein binders for therapeutic applications has motivated the development of various strategies for extending the in vivo half-life of such agents.Here
The smallest possible antigen binding domain has been built into a multimer molecule, dubbed as Combody, by fusing to a coiled-coil structure derived from cartilage oligomeric matrix protein.Combody h
Capillary electrophoresis (CE) technology has long been used for separation and analysis of pharmaceutical products.As the development of therapeutic monoclonal antibodies and other biologics increase